BIOMERICA INC Research and Development Expense
BIOMERICA INC (BMRA) reported Research and Development Expense of $788.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-31
- BIOMERICA INC research and development expense for the quarter ending 2026-05-31 was $205.00K, a 18.65% decline year-over-year.
- BIOMERICA INC research and development expense for the quarter ending 2026-02-28 was $178.00K, a 17.97% decline year-over-year.
- BIOMERICA INC research and development expense for the quarter ending 2025-11-30 was $193.00K, a 24.90% decline year-over-year.
- BIOMERICA INC research and development expense for the quarter ending 2025-08-31 was $212.00K, a 28.62% decline year-over-year.
- BIOMERICA INC research and development expense for fiscal 2026 was $788.00K, a 22.97% decline from fiscal 2025.
- BIOMERICA INC research and development expense for fiscal 2025 was $1.02M, a 31.39% decline from fiscal 2024.
- BIOMERICA INC research and development expense for fiscal 2024 was $1.49M, a 5.87% decline from fiscal 2023.
- BIOMERICA INC research and development expense for fiscal 2023 was $1.58M, a 12.58% decline from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $383.00K derived: sum of 2 quarters · filed 2026-08-31 | $576.00K derived: sum of 3 quarters · filed 2026-08-31 | $788.00K 10-K · filed 2026-08-31 | ||||
| 2026-02-28 | $178.00K 10-Q · filed 2026-04-13 | $371.00K derived: sum of 2 quarters · filed 2026-04-13 | $583.00K 10-Q · filed 2026-04-13 | $835.00K derived: sum of 4 quarters · filed 2026-08-31 | ||||
| 2025-11-30 | $193.00K 10-Q · filed 2026-01-14 | $405.00K 10-Q · filed 2026-01-14 | $657.00K derived: sum of 3 quarters · filed 2026-08-31 | $874.00K derived: sum of 4 quarters · filed 2026-08-31 | ||||
| 2025-08-31 | $212.00K 10-Q · filed 2025-10-14 | $464.00K derived: sum of 2 quarters · filed 2026-08-31 | $681.00K derived: sum of 3 quarters · filed 2026-08-31 | $938.00K derived: sum of 4 quarters · filed 2026-08-31 | ||||
| 2025-05-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $469.00K derived: sum of 2 quarters · filed 2026-08-31 | $726.00K derived: sum of 3 quarters · filed 2026-08-31 | $1.02M 10-K · filed 2026-08-31 | ||||
| 2025-02-28 | $217.00K 10-Q · filed 2026-04-13 | $474.00K derived: sum of 2 quarters · filed 2026-04-13 | $771.00K 10-Q · filed 2026-04-13 | $1.04M derived: sum of 4 quarters · filed 2026-04-13 | ||||
| 2024-11-30 | $257.00K 10-Q · filed 2026-01-14 | $554.00K 10-Q · filed 2026-01-14 | $819.00K derived: sum of 3 quarters · filed 2026-01-14 | $1.16M derived: sum of 4 quarters · filed 2026-01-14 | ||||
| 2024-08-31 | $297.00K 10-Q · filed 2025-10-14 | $562.00K derived: sum of 2 quarters · filed 2025-10-14 | $905.00K derived: sum of 3 quarters · filed 2025-10-14 | $1.32M derived: sum of 4 quarters · filed 2025-10-14 | ||||
| 2024-05-31 | $265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | $608.00K derived: sum of 2 quarters · filed 2025-08-29 | $1.02M derived: sum of 3 quarters · filed 2025-08-29 | $1.49M 10-K · filed 2025-08-29 | ||||
| 2024-02-29 | $343.00K 10-Q · filed 2025-04-14 | $755.00K derived: sum of 2 quarters · filed 2025-04-14 | $1.23M 10-Q · filed 2025-04-14 | $1.60M derived: sum of 4 quarters · filed 2025-04-14 | ||||
| 2023-11-30 | $412.00K 10-Q · filed 2025-01-14 | $883.00K 10-Q · filed 2025-01-14 | $1.25M derived: sum of 3 quarters · filed 2025-01-14 | $1.65M derived: sum of 4 quarters · filed 2025-01-14 | ||||
| 2023-08-31 | $472.00K 10-Q · filed 2024-10-15 | $841.00K derived: sum of 2 quarters · filed 2024-10-15 | $1.23M derived: sum of 3 quarters · filed 2024-10-15 | $1.70M derived: sum of 4 quarters · filed 2024-10-15 | ||||
| 2023-05-31 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $761.00K derived: sum of 2 quarters · filed 2024-08-28 | $1.22M derived: sum of 3 quarters · filed 2024-08-28 | $1.58M 10-K · filed 2024-08-28 | ||||
| 2023-02-28 | $392.00K 10-Q · filed 2024-04-12 | $392.03K 10-Q · filed 2023-04-14 | $854.00K derived: sum of 2 quarters · filed 2024-04-12 | $1.22M 10-Q · filed 2024-04-12 | $1.22M 10-Q · filed 2023-04-14 | $1.71M derived: sum of 4 quarters · filed 2024-04-12 | ||
| 2022-11-30 | $462.00K 10-Q · filed 2024-01-16 | $461.94K 10-Q · filed 2023-01-13 | $823.00K 10-Q · filed 2024-01-16 | $823.11K 10-Q · filed 2023-01-13 | $1.32M derived: sum of 3 quarters · filed 2024-01-16 | $1.71M derived: sum of 4 quarters · filed 2024-01-16 | ||
| 2022-08-31 | $361.00K 10-Q · filed 2023-10-12 | $361.17K 10-Q · filed 2022-10-13 | $856.42K derived: sum of 2 quarters · filed 2023-10-12 | $1.24M derived: sum of 3 quarters · filed 2023-10-12 | $1.79M derived: sum of 4 quarters · filed 2023-10-12 | |||
| 2022-05-31 | $495.42K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-25 | $882.52K derived: sum of 2 quarters · filed 2023-08-25 | $1.43M derived: sum of 3 quarters · filed 2023-08-25 | $1.81M 10-K · filed 2023-08-25 | $1.81M 10-K · filed 2022-08-29 | |||
| 2022-02-28 | $387.10K 10-Q · filed 2023-04-14 | $457.00K 10-Q · filed 2022-04-14 | $935.04K derived: sum of 2 quarters · filed 2023-04-14 | $1.32M 10-Q · filed 2023-04-14 | $1.52M 10-Q · filed 2022-04-14 | $1.62M derived: sum of 4 quarters · filed 2023-04-14 | ||
| 2021-11-30 | $547.93K 10-Q · filed 2023-01-13 | $618.52K 10-Q · filed 2022-01-12 | $929.48K 10-Q · filed 2023-01-13 | $1.06M 10-Q · filed 2022-01-12 | $1.23M derived: sum of 3 quarters · filed 2023-01-13 | $1.80M derived: sum of 4 quarters · filed 2023-01-13 | ||
| 2021-08-31 | $381.54K 10-Q · filed 2022-10-13 | $439.86K 10-Q · filed 2021-10-14 | $683.97K derived: sum of 2 quarters · filed 2022-10-13 | $1.25M derived: sum of 3 quarters · filed 2022-10-13 | $1.86M derived: sum of 4 quarters · filed 2022-10-13 | |||
| 2021-05-31 | $302.43K derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-29 | $866.39K derived: sum of 2 quarters · filed 2022-08-29 | $1.48M derived: sum of 3 quarters · filed 2022-08-29 | $2.19M 10-K · filed 2022-08-29 | $2.41M 10-K · filed 2021-08-27 | |||
| 2021-02-28 | $563.97K 10-Q · filed 2022-04-14 | $563.22K 10-Q · filed 2021-04-14 | $1.18M derived: sum of 2 quarters · filed 2022-04-14 | $1.89M 10-Q · filed 2022-04-14 | $1.82M 10-Q · filed 2021-04-14 | $2.58M derived: sum of 4 quarters · filed 2022-04-14 | ||
| 2020-11-30 | $616.56K 10-Q · filed 2022-01-12 | $586.40K 10-Q · filed 2021-01-14 | $1.33M 10-Q · filed 2022-01-12 | $1.26M 10-Q · filed 2021-01-14 | $2.01M derived: sum of 3 quarters · filed 2022-01-12 | $2.49M derived: sum of 4 quarters · filed 2022-01-12 | ||
| 2020-08-31 | $711.50K 10-Q · filed 2021-10-14 | $674.69K 10-Q · filed 2020-10-15 | $1.40M derived: sum of 2 quarters · filed 2021-10-14 | $1.87M derived: sum of 3 quarters · filed 2021-10-14 | $2.27M derived: sum of 4 quarters · filed 2021-10-14 | |||
| 2020-05-31 | $683.97K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-10-14 | $1.16M derived: sum of 2 quarters · filed 2021-10-14 | $1.56M derived: sum of 3 quarters · filed 2021-10-14 | $1.93M 10-K/A · filed 2021-10-14 | $1.91M 10-K · filed 2020-08-31 | |||
| 2020-02-29 | $473.28K 10-Q · filed 2021-04-14 | $878.13K derived: sum of 2 quarters · filed 2021-04-14 | $1.25M 10-Q · filed 2021-04-14 | $1.66M derived: sum of 4 quarters · filed 2021-04-14 | ||||
| 2019-11-30 | $404.85K 10-Q · filed 2021-01-14 | $775.32K 10-Q · filed 2021-01-14 | $1.18M derived: sum of 3 quarters · filed 2021-01-14 | $1.68M derived: sum of 4 quarters · filed 2021-01-14 | ||||
| 2019-08-31 | $370.47K 10-Q · filed 2020-10-15 | $779.28K derived: sum of 2 quarters · filed 2020-10-15 | $1.28M derived: sum of 3 quarters · filed 2020-10-15 | $1.66M derived: sum of 4 quarters · filed 2020-10-15 | ||||
| 2019-05-31 | $408.81K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-31 | $905.91K derived: sum of 2 quarters · filed 2020-08-31 | $1.29M derived: sum of 3 quarters · filed 2020-08-31 | $1.68M 10-K · filed 2020-08-31 | ||||
| 2019-02-28 | $497.10K 10-Q · filed 2020-04-14 | $878.51K derived: sum of 2 quarters · filed 2020-04-14 | $1.27M 10-Q · filed 2020-04-14 | $1.75M derived: sum of 4 quarters · filed 2020-04-14 | ||||
| 2018-11-30 | $381.40K 10-Q · filed 2020-01-14 | $773.19K 10-Q · filed 2020-01-14 | $1.26M derived: sum of 3 quarters · filed 2020-01-14 | $1.61M derived: sum of 4 quarters · filed 2020-01-14 | ||||
| 2018-08-31 | $391.78K 10-Q · filed 2019-10-15 | $875.57K derived: sum of 2 quarters · filed 2019-10-15 | $1.23M derived: sum of 3 quarters · filed 2019-10-15 | $1.50M derived: sum of 4 quarters · filed 2019-10-15 | ||||
| 2018-05-31 | $483.79K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-29 | $837.35K derived: sum of 2 quarters · filed 2019-08-29 | $1.11M derived: sum of 3 quarters · filed 2019-08-29 | $1.40M 10-K · filed 2019-08-29 | ||||
| 2018-02-28 | $353.56K 10-Q · filed 2019-04-15 | $626.00K derived: sum of 2 quarters · filed 2019-04-15 | $914.58K 10-Q · filed 2019-04-15 | $1.26M derived: sum of 4 quarters · filed 2019-04-15 | ||||
| 2017-11-30 | $272.44K 10-Q · filed 2019-01-14 | $561.02K 10-Q · filed 2019-01-14 | $909.73K derived: sum of 3 quarters · filed 2019-01-14 | $1.17M derived: sum of 4 quarters · filed 2019-01-14 | ||||
| 2017-08-31 | $288.58K 10-Q · filed 2018-10-15 | $637.29K derived: sum of 2 quarters · filed 2018-10-15 | $894.01K derived: sum of 3 quarters · filed 2018-10-15 | $1.19M derived: sum of 4 quarters · filed 2018-10-15 | ||||
| 2017-05-31 | $348.71K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-29 | $605.43K derived: sum of 2 quarters · filed 2018-08-29 | $906.39K derived: sum of 3 quarters · filed 2018-08-29 | $1.13M 10-K · filed 2018-08-29 | ||||
| 2017-02-28 | $256.72K 10-Q · filed 2018-04-16 | $557.68K derived: sum of 2 quarters · filed 2018-04-16 | $781.93K 10-Q · filed 2018-04-16 | $988.79K derived: sum of 4 quarters · filed 2018-04-16 | ||||
| 2016-11-30 | $300.96K 10-Q · filed 2018-01-17 | $525.21K 10-Q · filed 2018-01-17 | $732.07K derived: sum of 3 quarters · filed 2018-01-17 | $917.34K derived: sum of 4 quarters · filed 2018-01-17 | ||||
| 2016-08-31 | $224.25K 10-Q · filed 2017-10-16 | $431.11K derived: sum of 2 quarters · filed 2017-10-16 | $616.38K derived: sum of 3 quarters · filed 2017-10-16 | $846.59K derived: sum of 4 quarters · filed 2017-10-16 | ||||
| 2016-05-31 | $206.86K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-29 | $392.13K derived: sum of 2 quarters · filed 2017-08-29 | $622.34K derived: sum of 3 quarters · filed 2017-08-29 | $780.33K 10-K · filed 2017-08-29 | ||||
| 2016-02-29 | $185.27K 10-Q · filed 2017-04-14 | $415.48K derived: sum of 2 quarters · filed 2017-04-14 | $573.47K 10-Q · filed 2017-04-14 | $744.70K derived: sum of 4 quarters · filed 2017-04-14 | ||||
| 2015-11-30 | $230.21K 10-Q · filed 2017-01-17 | $388.21K 10-Q · filed 2017-01-17 | $559.43K derived: sum of 3 quarters · filed 2017-01-17 | $744.06K derived: sum of 4 quarters · filed 2017-01-17 | ||||
| 2015-08-31 | $157.99K 10-Q · filed 2016-10-17 | $329.21K derived: sum of 2 quarters · filed 2016-10-17 | $513.85K derived: sum of 3 quarters · filed 2016-10-17 | $695.93K derived: sum of 4 quarters · filed 2016-10-17 | ||||
| 2015-05-31 | $171.22K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $355.85K derived: sum of 2 quarters · filed 2016-08-29 | $537.94K derived: sum of 3 quarters · filed 2016-08-29 | $733.64K 10-K · filed 2016-08-29 | ||||
| 2015-02-28 | $184.63K 10-Q · filed 2016-04-14 | $366.72K derived: sum of 2 quarters · filed 2016-04-14 | $562.42K 10-Q · filed 2016-04-14 | $784.07K derived: sum of 4 quarters · filed 2016-04-14 | ||||
| 2014-11-30 | $182.09K 10-Q · filed 2016-01-14 | $377.79K 10-Q · filed 2016-01-14 | $599.44K derived: sum of 3 quarters · filed 2016-01-14 | $739.62K derived: sum of 4 quarters · filed 2016-01-14 | ||||
| 2014-08-31 | $195.71K 10-Q · filed 2015-10-15 | $417.35K derived: sum of 2 quarters · filed 2015-10-15 | $557.53K derived: sum of 3 quarters · filed 2015-10-15 | $694.32K derived: sum of 4 quarters · filed 2015-10-15 | ||||
| 2014-05-31 | $221.64K derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $361.82K derived: sum of 2 quarters · filed 2015-08-31 | $498.61K derived: sum of 3 quarters · filed 2015-08-31 | $589.87K 10-K · filed 2015-08-31 | ||||
| 2014-02-28 | $140.18K 10-Q · filed 2015-04-14 | $276.97K derived: sum of 2 quarters · filed 2015-04-14 | $368.22K 10-Q · filed 2015-04-14 | $473.40K derived: sum of 4 quarters · filed 2015-04-14 | ||||
| 2013-11-30 | $136.79K 10-Q · filed 2015-01-14 | $228.05K 10-Q · filed 2015-01-14 | $333.23K derived: sum of 3 quarters · filed 2015-01-14 | $483.41K derived: sum of 4 quarters · filed 2015-01-14 | ||||
| 2013-08-31 | $91.26K 10-Q · filed 2014-10-15 | $196.44K derived: sum of 2 quarters · filed 2014-10-15 | $346.62K derived: sum of 3 quarters · filed 2014-10-15 | $462.36K derived: sum of 4 quarters · filed 2014-10-15 | ||||
| 2013-05-31 | $105.18K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | $255.36K derived: sum of 2 quarters · filed 2014-08-29 | $371.11K derived: sum of 3 quarters · filed 2014-08-29 | $459.09K 10-K · filed 2014-08-29 | ||||
| 2013-02-28 | $150.18K 10-Q · filed 2014-04-14 | $265.92K derived: sum of 2 quarters · filed 2014-04-14 | $353.90K 10-Q · filed 2014-04-14 | $434.77K derived: sum of 4 quarters · filed 2014-04-14 | ||||
| 2012-11-30 | $115.74K 10-Q · filed 2014-01-14 | $203.72K 10-Q · filed 2014-01-14 | $284.59K derived: sum of 3 quarters · filed 2014-01-14 | $379.36K derived: sum of 4 quarters · filed 2014-01-14 | ||||
| 2012-08-31 | $87.98K 10-Q · filed 2013-10-15 | $168.85K derived: sum of 2 quarters · filed 2013-10-15 | $263.62K derived: sum of 3 quarters · filed 2013-10-15 | $349.17K derived: sum of 4 quarters · filed 2013-10-15 | ||||
| 2012-05-31 | $80.87K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $175.64K derived: sum of 2 quarters · filed 2013-08-29 | $261.19K derived: sum of 3 quarters · filed 2013-08-29 | $347.13K 10-K · filed 2013-08-29 | ||||
| 2012-02-29 | $94.77K 10-Q · filed 2013-04-15 | $180.32K derived: sum of 2 quarters · filed 2013-04-15 | $266.26K 10-Q · filed 2013-04-15 | $371.85K derived: sum of 4 quarters · filed 2013-04-15 | ||||
| 2011-11-30 | $85.55K 10-Q · filed 2013-01-14 | $171.49K 10-Q · filed 2013-01-14 | $277.08K derived: sum of 3 quarters · filed 2013-01-14 | $374.09K derived: sum of 4 quarters · filed 2013-01-14 | ||||
| 2011-08-31 | $85.94K 10-Q · filed 2012-10-12 | $191.53K derived: sum of 2 quarters · filed 2012-10-12 | $288.54K derived: sum of 3 quarters · filed 2012-10-12 | $408.65K derived: sum of 4 quarters · filed 2012-10-12 | ||||
| 2011-05-31 | $105.59K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | $202.60K derived: sum of 2 quarters · filed 2012-08-29 | $322.72K derived: sum of 3 quarters · filed 2012-08-29 | $420.57K 10-K · filed 2012-08-29 | ||||
| 2011-02-28 | $97.01K 10-Q · filed 2012-04-16 | $217.13K derived: sum of 2 quarters · filed 2012-04-16 | $314.98K 10-Q · filed 2012-04-16 | |||||
| 2010-11-30 | $120.12K 10-Q · filed 2012-01-17 | $217.97K 10-Q · filed 2012-01-17 | ||||||
| 2010-08-31 | $97.85K 10-Q/A · filed 2011-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |